Klotho Neurosciences (KLTO) Competitors $0.48 -0.03 (-5.58%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KLTO vs. FBRX, CYBN, NKTX, CLYM, MCRB, CRDF, LFVN, KALA, AVTX, and SKYEShould you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include Forte Biosciences (FBRX), Cybin (CYBN), Nkarta (NKTX), Climb Bio (CLYM), Seres Therapeutics (MCRB), Cardiff Oncology (CRDF), Lifevantage (LFVN), KALA BIO (KALA), Avalo Therapeutics (AVTX), and Skye Bioscience (SKYE). These companies are all part of the "pharmaceutical products" industry. Klotho Neurosciences vs. Its Competitors Forte Biosciences Cybin Nkarta Climb Bio Seres Therapeutics Cardiff Oncology Lifevantage KALA BIO Avalo Therapeutics Skye Bioscience Forte Biosciences (NASDAQ:FBRX) and Klotho Neurosciences (NASDAQ:KLTO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership. Is FBRX or KLTO more profitable? Forte Biosciences' return on equity of -85.38% beat Klotho Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets Forte BiosciencesN/A -85.38% -72.34% Klotho Neurosciences N/A -325.88%-242.15% Which has preferable earnings and valuation, FBRX or KLTO? Klotho Neurosciences is trading at a lower price-to-earnings ratio than Forte Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioForte BiosciencesN/AN/A-$35.48M-$16.29-0.87Klotho NeurosciencesN/AN/A-$6.15M-$0.45-1.06 Does the media prefer FBRX or KLTO? In the previous week, Klotho Neurosciences had 1 more articles in the media than Forte Biosciences. MarketBeat recorded 2 mentions for Klotho Neurosciences and 1 mentions for Forte Biosciences. Klotho Neurosciences' average media sentiment score of 1.91 beat Forte Biosciences' score of 1.30 indicating that Klotho Neurosciences is being referred to more favorably in the news media. Company Overall Sentiment Forte Biosciences Positive Klotho Neurosciences Very Positive Do analysts prefer FBRX or KLTO? Forte Biosciences currently has a consensus target price of $68.00, indicating a potential upside of 377.19%. Given Forte Biosciences' stronger consensus rating and higher probable upside, equities analysts plainly believe Forte Biosciences is more favorable than Klotho Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Klotho Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders have more ownership in FBRX or KLTO? 77.6% of Forte Biosciences shares are owned by institutional investors. Comparatively, 20.1% of Klotho Neurosciences shares are owned by institutional investors. 5.9% of Forte Biosciences shares are owned by company insiders. Comparatively, 26.7% of Klotho Neurosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, FBRX or KLTO? Forte Biosciences has a beta of 2.69, indicating that its stock price is 169% more volatile than the S&P 500. Comparatively, Klotho Neurosciences has a beta of 10.74, indicating that its stock price is 974% more volatile than the S&P 500. SummaryForte Biosciences beats Klotho Neurosciences on 7 of the 13 factors compared between the two stocks. Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KLTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLTO vs. The Competition Export to ExcelMetricKlotho NeurosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.01M$2.55B$5.75B$10.39BDividend YieldN/A54.21%5.75%4.64%P/E Ratio-1.0623.2675.7726.11Price / SalesN/A716.05544.74124.93Price / CashN/A176.2437.5461.24Price / Book11.935.1412.876.30Net Income-$6.15M$32.95M$3.29B$271.03M7 Day Performance-13.27%0.09%-0.26%-0.15%1 Month Performance-36.75%5.04%3.84%6.41%1 Year PerformanceN/A1.02%68.35%28.81% Klotho Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLTOKlotho Neurosciences0.6054 of 5 stars$0.48-5.6%N/AN/A$31.01MN/A-1.06N/ANews CoveragePositive NewsFBRXForte Biosciences3.1509 of 5 stars$12.33+7.4%$68.00+451.5%+114.3%$142.73MN/A-0.765High Trading VolumeCYBNCybin2.7046 of 5 stars$6.04+0.5%$85.00+1,307.3%N/A$142.48MN/A-1.3850NKTXNkarta2.1333 of 5 stars$1.95-1.0%$13.60+597.4%-56.6%$139.92MN/A-1.32140Positive NewsCLYMClimb Bio3.4753 of 5 stars$2.01-1.5%$9.00+347.8%N/A$138.24MN/A-2.879Analyst ForecastGap UpMCRBSeres Therapeutics1.7468 of 5 stars$17.40+10.9%$73.67+323.4%-12.7%$137.36M$126.32M-3.78330Analyst ForecastCRDFCardiff Oncology2.3115 of 5 stars$2.00-2.0%$10.63+431.3%-21.0%$135.71M$680K-2.3020Positive NewsLFVNLifevantage3.9629 of 5 stars$10.71+0.3%$30.50+184.8%-5.5%$135.54M$228.53M14.47260KALAKALA BIO4.1562 of 5 stars$18.32-4.8%$21.75+18.7%+246.7%$135.15M$3.89M-2.7030Gap UpAVTXAvalo Therapeutics3.9336 of 5 stars$9.76-3.7%$30.00+207.4%+19.0%$133.37M$440K0.0040Positive NewsSKYESkye Bioscience1.8162 of 5 stars$3.86-5.2%$15.50+301.6%-10.7%$126.12MN/A0.0011 Related Companies and Tools Related Companies Forte Biosciences Competitors Cybin Competitors Nkarta Competitors Climb Bio Competitors Seres Therapeutics Competitors Cardiff Oncology Competitors Lifevantage Competitors KALA BIO Competitors Avalo Therapeutics Competitors Skye Bioscience Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLTO) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLTO Stock Alerts